2.Artificial intelligence in dermatology: past, present, and future
Li CHENG-XU ; Shen CHANG-BING ; Xue KE ; Shen XUE ; Jing YAN ; Wang ZI-YI ; Xu FENG ; Meng RU-SONG ; Yu JIAN-BIN ; Cui YONG
Chinese Medical Journal 2019;132(17):2017-2020
3.Investigation of phased health education needs and anxiety status of preterm fathers
Jingjing QIAN ; Bian LI ; Jingwen MENG ; Hua CHEN ; Xifang RU ; Xiuting SONG ; Lili CHEN
Chinese Journal of Modern Nursing 2017;23(21):2735-2737
Objective To explore the postnatal health education needs of preterm fathers so as to provide evidences for the formulation of health education on preterm parents.Methods A total of 60 fathers of preterm infants admitted in Peking University First Hospital NICU from January 2015 to June 2015 were selected and surveyed at different time points including admission,discharge and the first follow-up. Preterm parents care needs questionnaire and State Anxiety Inventory (S-AI) were used to evaluate phased health education needs and anxiety status of preterm fathers.Results At the admission time, fathers care more about the condition and prognosis of preterm infants,with the S-AI score of (49.57±10.88). At the discharge time,preterm fathers showed great needs of nursing skills and ability,with skill need score of (20.27±6.07) and ability need score of (11.96±3.37). After the discharge,preterm fathers focused on feeding skills and knowledge of observation and treatment for special situations.Conclusions Preterm fathers have phased needs and anxiety for infants from admission to follow-up stage. Nurses need to provide phased and individual health education and support to increase the nursing ability of preterm parents so as to improve the psychological states of preterm parents.
4.Jinleng undershorts palliates varicocele.
Ji-Hong LIANG ; Xian-Zong MENG ; Guang-Yu LI ; Xun ZHANG ; Shi-Kun LIANG ; Chun-Hui ZHU ; Wei-Ru SONG ; Guo-Qiang WEI
National Journal of Andrology 2010;16(10):950-953
OBJECTIVETo investigate the effect of Jinleng undershorts on the elevated scrotal temperature induced by varicocele as well as on other clinical symptoms of the disease.
METHODSFifty-one varicocele patients received the treatment of wearing Jinleng undershorts for 30 min twice a day for a course of 90 days. Comparisons were made between the scrotal temperatures and other clinical symptoms of varicocele before and after the treatment.
RESULTSAfter 90 days of treatment with Jinleng undershorts, the left scrotal temperature of the varicocele patients was significantly reduced from (32.16 +/- 0.79) degrees C to (31.53 +/- 0.77) degrees C (P < 0.01), and the right scrotal temperature decreased from (31.91 +/- 0.73) degrees C to (31.81 +/- 0.63) degrees C (P > 0.05). Compared with pretreatment, significant improvement was found in such symptoms as wetness, fever and swelling of the scrotum, backache, headache, dizziness, fatigue and anxiety (P < 0.05), as well as in testicular pain (P < 0.01) and IIEF-5 score, which was increased from 15.89 +/- 6.13 to 20.04 +/- 3.87 (P < 0.01).
CONCLUSIONJinleng undershorts can be used for the treatment of mild and moderate varicocele.
Body Temperature ; Clothing ; Humans ; Male ; Medicine, Chinese Traditional ; Scrotum ; Varicocele ; therapy
5.Simultaneous analysis of telomere length and cell surface antigen in leukemia by multicolor Flow-FISH.
Yu ZHAN ; Ru FENG ; Zheng-Shan YI ; Lan-Lin SONG ; Qiang WANG ; Meng XU ; Yong-Qiang WEI
Journal of Experimental Hematology 2010;18(6):1395-1401
This study was purposed to explore the feasibility of simultaneous analysis of telomere length and cell surface antigen by multicolor Flow-FISH to assess minimal residual disease (MRD) in leukemia. The telomere length in 34 leukemia patients versus 20 normal controls was compared by using Flow-FISH, and the relationship between telomere length and therapeutic effect and prognosis was analyzed preliminarily. As for those patients with follow-up samples, the changes of telomere length combined with surface antigen in different courses of disease were observed by multicolor Flow-FISH. The results indicated that the telomere length of de novo patients was significantly shorter than that of controls except the patients in chronic myeloid leukemia-chronic phase (CML-CP). The shorter telomere, the lower complete remission (CR) rates were observed in acute leukemia cases and the shorter duration of CP before onset of blast phase (BP) occurred in CML cases. The acute leukemia patients showed longer telomere and fewer cells expressed the related antigen after CR. The telomere length of cases with continued CR remained at normal level during remission, and there was no increased expression of the specific antigen. However, the telomere of relapsed cases shortened again after relapse with elevated specific antigen expression. In the relapsed cases, the telomere of related antigen positive cells shortened ahead of telomere length change of the whole cells and morphologic change of bone marrow cells. It is concluded that analysis of telomere length by flow-FISH manifests the significance for monitoring disease conditions, estimating prognosis and guiding therapy in all kinds of leukemia. The simultaneous analysis of telomere length and cell surface antigen by multicolor flow-FISH may monitor abnormal clone or clonal evolution to predict recurrence more sensitively and specifically, and may provide a promising and widely applicable method for monitoring MRD in leukemia.
Adolescent
;
Adult
;
Aged
;
Antigens, Surface
;
analysis
;
Female
;
Flow Cytometry
;
Humans
;
In Situ Hybridization, Fluorescence
;
Leukemia
;
genetics
;
immunology
;
Male
;
Middle Aged
;
Neoplasm, Residual
;
genetics
;
immunology
;
Recurrence
;
Remission Induction
;
Telomere
;
genetics
;
Young Adult
6.Treatment of advanced neuroendocrine tumors with ~(90)Y-DOTATATE
Yong-hui, CHEN ; Fang, LI ; Bing, JIA ; Hong-li, JING ; Li-bo, CHEN ; Fang, CHEN ; Fan, WANG ; Yan-tong, DU ; Yan-ru, MA ; Meng, OUYANG ; Yan-song, LIN ; Zeng-shou, KANG
Chinese Journal of Nuclear Medicine 2010;30(1):1-4
Objective To evaluate the effcacy and side effects of [~(90)Y-1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic acid (DOTA)~0,Tyr3]octreotate (~(90)Y-DOTATATE) combined with lysine as a renal protective agent.Methods Twenty-five patients with advanced neuroendocrine tumors were confirmed as somatostatin receptor subtype-2 (SSTR2)-positive by somatostatin receptor scintigraphy (SRS).Each patient received 1-5 cycles of treatment and the interval between two cycles of treatment was 6-9 weeks.~(90)Y-DOTATATE was administered intravenously within 30 min.Lysine was injected before and after the administration of ~(90)Y-DOTATATE.After each treatment cycle.the side effects were assessed according to National Cancer Institute Grading Criteria(NCIGC).The etticacy was evaluated by the WHO criteria 8 weeks after the last treatment.Results Pattial remission was found in 1 patient (4%).minor response in 3 patients(12%),stable disease in 16 patients (64%)and tumor progression in 5 patients (20%).Two patients suffered from renal functional injuries and 3 patients developed leukocytopenia.Three patients showed nausea while another 3 patients presented vomiting.Conclusions ~(90)Y-DOTATATE in association with lysine may be a promising treatment method for the patients with metastatic and inoperable neuroendocrine tumors.More research work may be directed to reduce renal injury.
8.Clinical investigation of 144 patients with drug-induced liver injury and its influencing factors analysis
Pei-Pei MENG ; Shi-Kun LIU ; Yang HE ; Yu-Tao MA ; Shan-Ru ZUO ; Li-Ying SONG ; Chun-Jiang WANG
The Chinese Journal of Clinical Pharmacology 2017;33(5):467-469,473
Objective In order to provide support for the rational use of drugs,we summarize the clinical characteristics of patients with drug-induced liver injury (DILI) and statistics of the allergic drugs.Methods According to the common drug-induced liver injury diagnostic criteria of our country,the clinical data of 144 hospitalized cases in the third Xiangya hospital with DILI were analyzed retrospectively,then,potential pathogenic drugs were summarized.Results A total of 144 patients with DILI were enrolled in this study:male account for 53.47% (77/144 cases),female account for 46.53% (67/144 cases).The average age was (44.32 ± 16.02) years old,and 50.70% (73/144 cases) of the patients were over 40 years old.Liver injury was caused by several kinds of drugs,23.61% (34/144 cases) were traditional Chinese medicine,20.83% (30/144 cases)were immunosuppressive agents,15.97% (23/144 cases) were anti-tuberculosis drugs,7.64% (11/144 cases) were antineoplastic drugs.18.75% (27/144 cases) patients were cured,22.92% (33/144 cases) patients got better while others account for 58.33% (84/144 cases),and the average hospitalization days of patients with DILI were 16 days.Age,gender and duration of the disease had no significant effect on prognosis (P > 0.05),while there were significant differences between liver function indexes and prognosis (P <0.05).Conclusion In this study,the incidence of DILI was higher in elderly people.A variety of drugs were able to cause DILI,including traditional Chinese medicine,immunosuppressive agents and anti-tuberculosis drugs.
9.Summary of best evidence for prevention and management of nipple pain or injury in breastfeeding puerperae
Peng YU ; Xiuhong SONG ; Meng ZHANG ; Jing WANG ; Jian MA ; Yan WANG ; Ru XU ; Juan WANG ; Guofang KUANG
Chinese Journal of Modern Nursing 2023;29(29):4032-4037
Objective:To retrieve, evaluate, and summarize the best evidence for the prevention and management of nipple pain or injury in breastfeeding puerperae, providing evidence-based basis for clinical practice of breastfeeding.Methods:According to the "6S" evidence pyramid model, clinical decisions, guidelines, expert consensus, evidence summaries, and systematic reviews on the prevention and management of nipple pain or injury in breastfeeding puerperae were systematically searched. The search period was from database establishment to March 10, 2023. The research team members independently evaluated the quality of the included article based on the corresponding quality evaluation standards, and combined professional judgment to extract and summarize evidence for the final included article.Results:A total of 15 articles were included, including two clinical decisions, 7 guidelines, and 6 systematic reviews. Finally, 19 best pieces of evidence were summarized, including four themes, namely, assessment of nipple pain or injury, prevention of nipple pain or injury, management of nipple pain or injury, and health education.Conclusions:Obstetrical nurses and midwives should provide standardized nursing for breastfeeding puerperae based on specific clinical scenarios, reduce the incidence of nipple pain or injury in breastfeeding puerperae, and promote puerperae to adhere to breastfeeding.
10.Low-dose testosterone undecanoate capsules combined with tadalafil for late-onset hypogonadism accompanied with ED.
Guang-Yu LI ; Ji-Hong LIANG ; Zhi-Bin MENG ; Cun-Chao HUANG ; Shi-Kun LIANG ; Guo-Qiang WEI ; Shu-Lin SHEN ; Chun-Hui ZHU ; Xun ZHANG ; Wei-Ru SONG
National Journal of Andrology 2013;19(7):630-633
OBJECTIVETo observe the clinical effect of low-dose testosterone undecanoate capsules combined with tadalafil on late-onset hypogonadism (LOH) accompanied with ED.
METHODSNinety cases of LOH accompanied with ED who met the inclusion criteria were randomly divided into a control group and a combination therapy group, the former treated with tadalafil and the latter with low-dose testosterone undecanoate capsules combined with tadalafil. The LOH symptoms, IIEF-5 scores, sexual encounter profile (SEP) scores, prostate volumes, and the levels of total testosterone (TT), free testosterone (FT) and prostatic specific antigen (PSA) were recorded and compared between the two groups before and after treatment.
RESULTSThe IIEF-5 and SEP scores and the TT and FT levels were 20.6 +/- 3.8, 4.02 +/- 1.08, (15.4 +/- 3.4) nmol/L and (0.391 +/- 0.062) nmol/L, respectively, in the combination therapy group after treatment, significantly higher both than 15.7 +/- 3.9, 1.49 +/- 0.82, (10.1 +/- 1.2) nmol/L and (0.200 +/- 0.045) nmol/L before treatment (P < 0.01) and than 8.6 +/- 3.6, 3.50 +/- 1.21, (10.2 +/- 1.2) nmol/L and (0.210 +/- 0.051) nmol/L in the control group after treatment (P < 0.01).
CONCLUSIONLow-dose testosterone undecanoate capsules combined with tadalafil has a definite clinical effect and no obvious adverse reactions in the treatment of LOH accompanied with ED.
Adult ; Carbolines ; administration & dosage ; therapeutic use ; Drug Therapy, Combination ; Erectile Dysfunction ; complications ; drug therapy ; Humans ; Hypogonadism ; complications ; drug therapy ; Male ; Middle Aged ; Tadalafil ; Testosterone ; administration & dosage ; analogs & derivatives ; therapeutic use ; Treatment Outcome